Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Circulation
|
February 19, 2004
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients
A Srámek, P Bucciarelli, A B Federici, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 7, 2013
Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report
E Berntorp, B Fuchs, M Makris, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 5, 2013
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
A Gringeri, C Leissinger, P A Cortesi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 27, 2020
Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate
G Castaman, A Borchiellini, E Santagostino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 11, 2012
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease
G Castaman, A Coppola, E Zanon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 20, 2016
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A
R Klamroth, M Simpson, M von Depka-Prondzinski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 24, 2003
Consensus perspectives on prophylactic therapy for haemophilia: summary statement
E Berntorp, J Astermark, S Björkman, et al.
Haematologica
|
October 1, 1979
[Thrombocythemias (author's transl)]
S Tura, G Alimena, T Artusi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 19, 2014
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey
M Franchini, A Coppola, A Rocino, et al.
Seminars in Hematology
|
December 6, 2001
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia
M C Poon, R d'Oiron, I Hann, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Circulation
|
February 19, 2004
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients
A Srámek, P Bucciarelli, A B Federici, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 7, 2013
Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report
E Berntorp, B Fuchs, M Makris, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 5, 2013
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study
A Gringeri, C Leissinger, P A Cortesi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 27, 2020
Non-Compartment and compartmental pharmacokinetics, efficacy, and safety of Kedrion FIX concentrate
G Castaman, A Borchiellini, E Santagostino, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 11, 2012
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease
G Castaman, A Coppola, E Zanon, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
July 20, 2016
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A
R Klamroth, M Simpson, M von Depka-Prondzinski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 24, 2003
Consensus perspectives on prophylactic therapy for haemophilia: summary statement
E Berntorp, J Astermark, S Björkman, et al.
Haematologica
|
October 1, 1979
[Thrombocythemias (author's transl)]
S Tura, G Alimena, T Artusi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 19, 2014
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey
M Franchini, A Coppola, A Rocino, et al.
Seminars in Hematology
|
December 6, 2001
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia
M C Poon, R d'Oiron, I Hann, et al.
Page
of 16